Multi-Step Continuous Flow Chemistry.

Phlow applies continuous flow chemistry to improve the safety, speed, and scalability of pharmaceutical manufacturing. By strategically integrating flow technologies into development and commercial processes, we help clients reduce technical risk, accelerate timelines, and enable reliable scale-up.

Strategic Integration of Continuous Flow Chemistry.

Phlow’s core technology includes cGMP-scale continuous flow chemistry, applied strategically where it delivers clear technical, safety, or economic advantages. While flow chemistry can be used to link multiple reaction and workup steps into integrated sequences, it is more often deployed within a hybrid manufacturing strategy, embedded into an otherwise traditional batch process at points where enhanced control is critical.

In these applications, flow enables precise control of residence time, temperature, pressure, and concentration for high-energy, fast, or selectivity-sensitive transformations, improving robustness and scalability. By integrating flow unit operations where they add the most value, Phlow reduces risk, enhances safety, and enables predictable scale-up, while maintaining the flexibility and familiarity of batch manufacturing for isolation, purification, and downstream finishing.

How Flow Enables Your Program.

Manufacturing Control

Steady‑state operation with continuous, inline analytical monitoring enables tighter control strategies than traditional batch processing.

Predictable Scale-up

Throughput is increased by numbering‑up while maintaining developed conditions, avoiding fundamental re‑optimization driven by vessel size.

Reduced Timelines

Multi‑step flow cascades eliminate unit-operation downtime and intermediate holds, materially reducing end‑to‑end production timelines for complex APIs.

Improved Sustainability & Efficiency

Demonstrated reductions in process mass intensity through improved kinetics, fewer workups, and reduced purification burden.

Safer Execution of High-Energy Chemistry

Small reaction volumes decouple hazard from throughput, enabling exothermic, high‑pressure, or otherwise constrained chemistries that are difficult to scale safely in batch.

Demonstrated Results

Completed U.S.-based cGMP multi-step continuous manufacturing campaign

From process development through commercial manufacturing, flow chemistry enables Phlow to deliver scalable, reproducible processes with enhanced safety, efficiency, and operational control.

78%
REDUCTION IN PRODUCTION TIME From 23 days (Benchmark Process) to 5 days using continuous manufacturing (Steps 1–4).
41%
reduction of process waste Phlow PMI = 118
Benchmark PMI = 200.
Less solvent, lower per-kg cost.
12
principles of green chemistry Waste reduction.
Atom Economy.
Energy Efficiency.
Multi-step continuous manufacturing is a proven capability at Phlow. Applied selectively and executed under cGMP, it enables safer, faster, and more efficient production of complex APIs at commercial scale.

Advance Mission-Critical Manufacturing.

Start the Conversation

Explore how Phlow’s flow chemistry expertise strengthens resilient pharmaceutical manufacturing.